Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/22/2026 | $15.00 | Buy → Hold | Jefferies |
| 12/3/2025 | $14.00 | Outperform → Market Perform | Leerink Partners |
| 12/3/2025 | $13.00 | Neutral → Underperform | BofA Securities |
| 9/10/2025 | $25.00 | Buy → Neutral | BofA Securities |
| 8/14/2025 | $26.00 | Strong Buy → Outperform | Raymond James |
| 2/28/2025 | $43.00 → $35.00 | Overweight → Equal Weight | Barclays |
| 1/7/2025 | $70.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 12/12/2024 | $45.00 → $75.00 | Hold → Buy | Deutsche Bank |
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
Wade D. Miquelon to Retire from the Board at Upcoming Annual Meeting Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. Cancelmi is a seasoned finance leader with an expansive knowledge of healthcare and a proven track record of driving superior financial performance. Most recently, he served as Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, where he played a significant role in the company's transformation and in strengthening its balance sheet. Over the course of his three-decade career at Tenet, he held a range of finance roles of in
GAD Therapies Market Set to Explode to $4.26B by 2033 as Demand Rockets for Innovative Anxiety Solutions NEW YORK, March 5, 2026 /CNW/ -- Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions of people dealing with constant worry and stress. Traditional medications like anti-anxiety drugs and antidepressants still play a big role, but therapy options such as cognitive-behavioral therapy and mindfulness techniques are also helping people manage symptoms without relying only on medication. Digital mental health tools and telehealth visits are making treatment easier to access, especially f
Company Provides First Quarter and Full Year 2026 Guidance Debbie Osteen Joins Acadia as Chief Executive Officer Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company's previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an increase in patient days of 3.1% and an increase in revenue per patient day of 1.3% Net loss attributable
Jefferies downgraded Acadia Healthcare from Buy to Hold and set a new price target of $15.00
Leerink Partners downgraded Acadia Healthcare from Outperform to Market Perform and set a new price target of $14.00
BofA Securities downgraded Acadia Healthcare from Neutral to Underperform and set a new price target of $13.00
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
SCHEDULE 13G - Acadia Healthcare Company, Inc. (0001520697) (Subject)
Wade D. Miquelon to Retire from the Board at Upcoming Annual Meeting Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. Cancelmi is a seasoned finance leader with an expansive knowledge of healthcare and a proven track record of driving superior financial performance. Most recently, he served as Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, where he played a significant role in the company's transformation and in strengthening its balance sheet. Over the course of his three-decade career at Tenet, he held a range of finance roles of in
Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D
Young Brings 25 Years of Financial and Healthcare Industry Experience Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") today announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Tim Sides, who has been serving as the Company's interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance. Young brings to Acadia nearly a decade of executive-level finance experience at publicly traded healthcare companies. He most recently served as CFO at Elanco Animal Health ("Elanco") where he joined in 2018 as Elanco was separating from Eli Lilly and Company. Young developed a robust finance organiza
Company Provides First Quarter and Full Year 2026 Guidance Debbie Osteen Joins Acadia as Chief Executive Officer Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company's previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an increase in patient days of 3.1% and an increase in revenue per patient day of 1.3% Net loss attributable
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States (the "U.S."). As of September 30, 2025, Acadia operated a network of
Third Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year Lowering Full-Year Outlook Acadia Taking Decisive Actions to Optimize Portfolio in Order to Reduce Capital Expenditures and Increase Free Cash Flow Generation Referral Initiatives Drive Accelerating Admissions Growth Todd Young joined as CFO on October 27; Announces departure of COO Dr. Nasser Khan Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Results Revenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024 Same facility revenue increased 3.7% compared with th
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)